Japan to improve blood products independence through merger of plasma producers
This article was originally published in Scrip
Executive Summary
Mitsubishi Tanabe Pharma (MTP) has entered into discussions for the integration of its Benesis blood plasma derivatives subsidiary with the plasma fractionation operations of the Japanese Red Cross Society (JRC), in a move the two sides say will improve Japan's self-sufficiency in such products.